Roivant Sciences Performance
| ROIVWDelisted Stock | USD 2.68 0.36 11.84% |
The company holds a Beta of -0.0836, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Roivant Sciences are expected to decrease at a much lower rate. During the bear market, Roivant Sciences is likely to outperform the market. Roivant Sciences right now holds a risk of 0.0%. Please check Roivant Sciences maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if Roivant Sciences will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Roivant Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Roivant Sciences is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 2.1 B |
Roivant |
Roivant Sciences Relative Risk vs. Return Landscape
If you would invest 268.00 in Roivant Sciences on August 25, 2024 and sell it today you would earn a total of 0.00 from holding Roivant Sciences or generate 0.0% return on investment over 90 days. Roivant Sciences is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than Roivant, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Roivant Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Roivant Sciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Roivant Sciences, and traders can use it to determine the average amount a Roivant Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ROIVW |
Based on monthly moving average Roivant Sciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Roivant Sciences by adding Roivant Sciences to a well-diversified portfolio.
Roivant Sciences Fundamentals Growth
Roivant Stock prices reflect investors' perceptions of the future prospects and financial health of Roivant Sciences, and Roivant Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Roivant Stock performance.
| Operating Margin | (37.08) % | |||
| Revenue | 61.28 M | |||
| EBITDA | (1.11 B) | |||
| Cash And Equivalents | 2 B | |||
| Cash Per Share | 8.97 X | |||
| Total Debt | 481.4 M | |||
| Debt To Equity | 0.13 % | |||
| Book Value Per Share | 7.74 X | |||
| Cash Flow From Operations | (843.39 M) | |||
| Earnings Per Share | (4.09) X | |||
| Total Asset | 2.39 B | |||
| Retained Earnings | (3.77 B) | |||
About Roivant Sciences Performance
Evaluating Roivant Sciences' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Roivant Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Roivant Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company was founded in 2014 and is based in London, the United Kingdom. Roivant Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 620 people.Things to note about Roivant Sciences performance evaluation
Checking the ongoing alerts about Roivant Sciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Roivant Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Roivant Sciences is not yet fully synchronised with the market data | |
| Roivant Sciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 61.28 M. Net Loss for the year was (1.12 B) with profit before overhead, payroll, taxes, and interest of 0. | |
| Roivant Sciences has accumulated about 2 B in cash with (843.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.97, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Roivant Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Roivant Sciences' stock is overvalued or undervalued compared to its peers.
- Examining Roivant Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Roivant Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Roivant Sciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Roivant Sciences' stock. These opinions can provide insight into Roivant Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Roivant Stock
If you are still planning to invest in Roivant Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Roivant Sciences' history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |